Silk Road Medical to Present at the 39th Annual J.P. Morgan Healthcare Conference
Silk Road Medical, Inc. (NASDAQ: SILK) announced its participation in the 39th Annual J.P. Morgan Healthcare Conference. Management is set to present on January 12, 2021, at 11:40 a.m. Eastern Time. The live and archived webcast can be accessed in the 'Investors' section on their website. Silk Road Medical is dedicated to reducing stroke risks, notably through their flagship procedure, TransCarotid Artery Revascularization (TCAR), which effectively treats carotid artery blockages.
- None.
- None.
SUNNYVALE, Calif., Dec. 17, 2020 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced the company will be participating in the upcoming 39th Annual J.P. Morgan Healthcare Conference.
Silk Road Medical’s management is scheduled to present on Tuesday, January 12, 2021 at 11:40 a.m. Eastern Time. Interested parties may access a live and archived webcast of the presentation on the “Investors” section of the company’s website at: https://investors.silkroadmed.com/.
About Silk Road Medical
Silk Road Medical, Inc. (NASDAQ: SILK), is a medical device company located in Sunnyvale, California, that is focused on reducing the risk of stroke and its devastating impact. The company’s flagship procedure, TransCarotid Artery Revascularization (TCAR), is clinically proven to treat blockages in the carotid artery at risk of causing a stroke. For more information on how Silk Road Medical is delivering brighter patient outcomes through brighter clinical thinking, visit www.silkroadmed.com and connect on Twitter, LinkedIn and Facebook.
Investor Contact:
Lynn Lewis or Caroline Paul
Gilmartin Group
investors@silkroadmed.com
FAQ
When is Silk Road Medical's presentation at the J.P. Morgan Healthcare Conference?
How can I access Silk Road Medical's webcast?
What is the focus of Silk Road Medical?
What is the ticker symbol for Silk Road Medical?
